{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T16:32:46Z","timestamp":1740155566578,"version":"3.37.3"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,2,5]],"date-time":"2013-02-05T00:00:00Z","timestamp":1360022400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1038\/nrendo.2013.18","type":"journal-article","created":{"date-parts":[[2013,2,5]],"date-time":"2013-02-05T06:57:27Z","timestamp":1360047447000},"page":"141-143","source":"Crossref","is-referenced-by-count":0,"title":["Tailoring antihypertensive drug treatment to body size"],"prefix":"10.1038","volume":"9","author":[{"given":"Guido","family":"Grassi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Mancia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,2,5]]},"reference":[{"key":"BFnrendo201318_CR1","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1097\/HJH.0b013e3281fc975a","volume":"25","author":"G Mancia","year":"2007","unstructured":"Mancia, G.  et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J. Hypertens. 25, 1105\u20131187 (2007).","journal-title":"J. Hypertens."},{"key":"BFnrendo201318_CR2","doi-asserted-by":"publisher","unstructured":"Weber, M. A.  et al. Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomized controlled trial. Lancet \n                    http:\/\/dx.doi.org\/10.1016\/S0140-6736(12)61343-9\n                    \n                  .","DOI":"10.1016\/S0140-6736(12)61343-9"},{"key":"BFnrendo201318_CR3","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1056\/NEJMoa0806182","volume":"359","author":"K Jamerson","year":"2008","unstructured":"Jamerson K.  et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N. Engl. J. Med. 359, 2417\u20132428 (2008).","journal-title":"N. Engl. J. Med."},{"key":"BFnrendo201318_CR4","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1097\/HJH.0b013e32831dafaf","volume":"27","author":"MP Schlaich","year":"2009","unstructured":"Schlaich, M. P.  et al. European Society of Hypertension Working Group on Obesity. Obesity-induced hypertension and target organ damage: current knowledge and future directions. J. Hypertens. 27, 207\u2013211 (2009).","journal-title":"J. Hypertens."},{"key":"BFnrendo201318_CR5","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1161\/01.HYP.36.4.538","volume":"36","author":"G Grassi","year":"2000","unstructured":"Grassi, G.  et al. Adrenergic and reflex abnormalities in obesity-related hypertension. Hypertension 36, 538\u2013542 (2000).","journal-title":"Hypertension"},{"key":"BFnrendo201318_CR6","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1038\/ajh.2010.172","volume":"23","author":"TA Kotchen","year":"2010","unstructured":"Kotchen, T. A. Obesity-related hypertension. epidemiology, pathophysiology, and clinical management. Am. J. Hypertens. 23, 1170\u20131178 (2010).","journal-title":"Am. J. Hypertens."},{"key":"BFnrendo201318_CR7","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1097\/HJH.0b013e3283537347","volume":"30","author":"J Jordan","year":"2012","unstructured":"Jordan, J.  et al. Joint statement of the European Association for the Study of Obesity and the European Society of Hypertension: obesity and difficult to treat arterial hypertension. J. Hypertens. 30, 1047\u20131055 (2012).","journal-title":"J. Hypertens."},{"key":"BFnrendo201318_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/01.hjh.0000194119.42722.21","volume":"24","author":"G Mancia","year":"2006","unstructured":"Mancia, G., Grassi, G. & Zanchetti, A. New-onset diabetes and antihypertensive drugs. J. Hypertens. 24, 3\u201310 (2006).","journal-title":"J. Hypertens."},{"key":"BFnrendo201318_CR9","doi-asserted-by":"publisher","unstructured":"Messerli, F. H. & Bangalore, S. Diuretic-based regimens for obese patients? Lancet \n                    http:\/\/dx.doi.org\/10.1016\/S0140-6736(12)61819-4\n                    \n                  .","DOI":"10.1016\/S0140-6736(12)61819-4"}],"container-title":["Nature Reviews Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrendo.2013.18","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrendo.2013.18.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrendo.2013.18.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T03:41:29Z","timestamp":1684467689000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrendo.2013.18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,5]]},"references-count":9,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["BFnrendo201318"],"URL":"https:\/\/doi.org\/10.1038\/nrendo.2013.18","relation":{},"ISSN":["1759-5029","1759-5037"],"issn-type":[{"type":"print","value":"1759-5029"},{"type":"electronic","value":"1759-5037"}],"subject":[],"published":{"date-parts":[[2013,2,5]]}}}